Tert-butyl(2s,5s)-5-(hydroxymethyl)-2-methyl-piperidine-1-carboxylate, 98%, 500mg

4,5-Dichloro-2-hydroxy-benzaldehyde, 97.0%, 250mg

4,5-Difluoro-2-nitroaniline, 98.0%, 25g

3-(tert-Butoxycarbonylamino)-3-methylbutanoic acid, 98.0%, 25g

2-Fluoro-6-nitrobenzonitrile, 95.0%, 5g

5-(chloromethyl)-2-methanesulfonyl-1-[(oxolan-2-yl)methyl]-1H-imidazole, 95.0%, 2g

TERT-BUTYL PYRAZOLO[1,5-A]PYRIMIDIN-2-YLCARBAMATE, 97.0%, 250mg

1-[2-(methylsulfonyl)ethyl]-4-piperidinamine dihydrochloride hydrate, 95.0%, 250mg

(S)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-ol, 95%, 500mg

4,6-Dichloro-3H-[1,2,3]triazolo[4,5-c]pyridine, 95%, 10g

N,N-DIoctyl-Formamide, 95%, 100mg

Di-tert-butyl (chloromethyl) phosphate (stabilised over Potassium Carbonate), 95.0%, 5g

Vial de reacción con brida plana, cilíndrico, graduado, con camisa atemperada, pieza de conexión KF, DN 150, 4000 ml, 190 mm, 1 pieza